Cellebrite DI: Continuous Innovation Including AI Can Drive Growth
The article says Cellebrite’s Q3 revenue rose 18% to $149 million and ARR grew 20% to $528.5 million, with federal and international demand supporting growth. The company raised its 2026 adjusted EBITDA guidance to $163 million–$166 million.
Why it matters — The reported growth, demand sources, and higher guidance are relevant indicators for investors following CLBT’s business performance.